DrugDashboards

Carisoprodol

Carisoprodol · CARISOPRODOL 350 mg/1 · Tablet · Actavis Pharma, Inc.

NDC 00591-5513-00 · 22200 TABLET in 1 BAG · DRUG FOR FURTHER PROCESSING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 50228-0109-05) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of saleⓘ
$0.1410per unit
middle half $0.0802–$0.2173 · 699 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $0.1410
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
13%of plans cover it
tier 2 · prior auth 28% · step therapy 0% · qty limit 30%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for carisoprodol (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $16.34 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Opioid Analgesic REMS Shared System REMS

Regulatory

Application
—
TE code
—
Approval date
—
Patents / exclusivity
—

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Carisoprodol (Tablet)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsCARISOPRODOL 350 mg/1Jul 15, 2026Sep 3, 2026
Aphena Pharma Solutions - Tennessee, LLCCARISOPRODOL 350 mg/1Jul 15, 2026Sep 3, 2026
Aurobindo Pharma LimitedCARISOPRODOL 350 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackCARISOPRODOL 350 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackCARISOPRODOL 250 mg/1Jul 15, 2026Sep 3, 2026
Direct_RxCARISOPRODOL 350 mg/1Jul 15, 2026Sep 3, 2026
PD-Rx Pharmaceuticals, Inc.CARISOPRODOL 350 mg/1Jul 15, 2026Sep 3, 2026
Proficient Rx LPCARISOPRODOL 350 mg/1Jul 15, 2026Sep 3, 2026
Actavis Pharma, Inc.CARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Advanced Rx Pharmacy of Tennessee, LLCCARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Asclemed USA, Inc.CARISOPRODOL 250 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCCARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
DirectrxCARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Granulation Technology, Inc.CARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Ingenus Pharmaceuticals, LLCCARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Medsource PharmaceuticalsCARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.CARISOPRODOL 250 mg/1Jul 15, 2026Sep 2, 2026
Northwind Health Company, LLCCARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Oxford Pharmaceuticals, LLCCARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.CARISOPRODOL 250 mg/1Jul 15, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.CARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
ScieGen Pharmaceuticals, Inc.CARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
St. Mary's Medical Park PharmacyCARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Vensun Pharmaceuticals, Inc.CARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Viatris Specialty LLCCARISOPRODOL 250 mg/1Jul 15, 2026Sep 2, 2026
Viatris Specialty LLCCARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Westminster Pharmaceuticals, LLCCARISOPRODOL 250 mg/1Jul 15, 2026Sep 2, 2026
Westminster Pharmaceuticals, LLCCARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Wilshire Pharmaceuticals, Inc.CARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Wilshire Pharmaceuticals, Inc.CARISOPRODOL 250 mg/1Jul 15, 2026Sep 2, 2026
Asclemed USA, Inc.CARISOPRODOL 350 mg/1Jul 15, 2026Aug 31, 2026
Remedyrepack Inc.CARISOPRODOL 350 mg/1Jul 15, 2026Aug 31, 2026
NuCare Pharmaceuticals,Inc.CARISOPRODOL 350 mg/1Jul 15, 2026Aug 29, 2026
Aurobindo Pharma LimitedCARISOPRODOL 250 mg/1Jul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Carisoprodol — NDC 00591-5513-00," retrieved September 3, 2026, https://drugdashboards.com/drug/00591551300.

Free to cite with attribution — see how the data is put together.